Goldman Sachs’s Eton Pharmaceutcials ETON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$13.5M Buy
262,778
+130,195
+98% +$6.61M ﹤0.01% 2932
2026
Q2
$4.8M Sell
132,583
-84,863
-39% -$2.49M ﹤0.01% 3910
2026
Q1
$5.37M Buy
217,446
+21,183
+11% +$370K ﹤0.01% 3626
2025
Q4
$3.32M Buy
196,263
+6,099
+3% +$107K ﹤0.01% 4132
2025
Q3
$4.13M Buy
190,164
+80,785
+74% +$1.34M ﹤0.01% 3822
2025
Q2
$1.56M Sell
109,379
-65,841
-38% -$1.04M ﹤0.01% 4369
2025
Q1
$2.27M Buy
175,220
+45,341
+35% +$685K ﹤0.01% 4045
2024
Q4
$1.73M Buy
+129,879
New +$1.32M ﹤0.01% 4408
2024
Q3
– Sell
-57,503
Closed -$189K – 5887
2024
Q2
$189K Sell
57,503
-61,352
-52% -$215K ﹤0.01% 5286
2024
Q1
$446K Buy
+118,855
New +$519K ﹤0.01% 4800
2023
Q4
– Sell
-25,650
Closed -$107K – 5680
2023
Q3
$107K Buy
+25,650
New +$99K ﹤0.01% 5167
2022
Q2
– Sell
-17,610
Closed -$77K – 6519
2022
Q1
$77K Buy
+17,610
New +$69.3K ﹤0.01% 6177
2021
Q4
– Sell
-20,446
Closed -$103K – 6513
2021
Q3
$103K Buy
+20,446
New +$106K ﹤0.01% 5903

Other funds holding ETON

Goldman Sachs's ETON Position: Q3 2026 in Review

Goldman Sachs increased its Eton Pharmaceutcials (ETON) stake by 98% in Q3 2026, buying an estimated $6.61M and bringing the position to 262,778 shares worth $13.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2932.

Goldman Sachs first reported a position in ETON in Q3 2021 and has held it in 13 quarters since. 213 funds tracked by Wall St. Rank hold ETON as of Q3 2026.

  • Goldman Sachs held 262,778 shares of Eton Pharmaceutcials worth $13.5M as of Q3 2026.
  • Goldman Sachs bought 130,195 Eton Pharmaceutcials shares in Q3 2026, an estimated $6.61M.
  • Eton Pharmaceutcials made up ﹤0.01% of Goldman Sachs's portfolio in Q3 2026, its #2932 holding.
  • Goldman Sachs first reported a position in Eton Pharmaceutcials in Q3 2021 and has held it in 13 quarters since.
  • 213 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q3 2026.

Based on Goldman Sachs's 13F filing for Q3 2026, filed 16 Nov 2026.